Matas-Céspedes, A., Vidal-Crespo, A., Rodriguez, V., Villamor, N., Delgado, J., Giné, E., . . . Pérez-Galán, P. (2016). The human CD38 monoclonal antibody daratumumab shows anti-tumor activity and hampers leukemia-microenvironment interactions in chronic lymphocytic leukemia. Clin Cancer Res.
Čikaški stil citiranjaMatas-Céspedes, Alba, et al. "The Human CD38 Monoclonal Antibody Daratumumab Shows Anti-tumor Activity and Hampers Leukemia-microenvironment Interactions in Chronic Lymphocytic Leukemia." Clin Cancer Res 2016.
MLA način citiranjaMatas-Céspedes, Alba, et al. "The Human CD38 Monoclonal Antibody Daratumumab Shows Anti-tumor Activity and Hampers Leukemia-microenvironment Interactions in Chronic Lymphocytic Leukemia." Clin Cancer Res 2016.